Order Article Reprints

Dziewierz A, Zdzierak B, Malinowski KP, Siudak Z, Zasada W, Tokarek T, Zabojszcz M, Dolecka-Ślusarczyk M, Dudek D, Bartuś S, et al. Diabetes Mellitus Is Still a Strong Predictor of Periprocedural Outcomes of Primary Percutaneous Coronary Interventions in Patients Presenting with ST-Segment Elevation Myocardial Infarction (from the ORPKI Polish National Registry). Journal of Clinical Medicine. 2022; 11(21):6284. https://doi.org/10.3390/jcm11216284

Dziewierz, Artur, Barbara Zdzierak, Krzysztof P. Malinowski, Zbigniew Siudak, Wojciech Zasada, Tomasz Tokarek, Michał Zabojszcz, Magdalena Dolecka-Ślusarczyk, Dariusz Dudek, Stanisław Bartuś, and et al. 2022. "Diabetes Mellitus Is Still a Strong Predictor of Periprocedural Outcomes of Primary Percutaneous Coronary Interventions in Patients Presenting with ST-Segment Elevation Myocardial Infarction (from the ORPKI Polish National Registry)" Journal of Clinical Medicine 11, no. 21: 6284. https://doi.org/10.3390/jcm11216284

Dziewierz, A., Zdzierak, B., Malinowski, K. P., Siudak, Z., Zasada, W., Tokarek, T., Zabojszcz, M., Dolecka-Ślusarczyk, M., Dudek, D., Bartuś, S., Surdacki, A., & Rakowski, T. (2022). Diabetes Mellitus Is Still a Strong Predictor of Periprocedural Outcomes of Primary Percutaneous Coronary Interventions in Patients Presenting with ST-Segment Elevation Myocardial Infarction (from the ORPKI Polish National Registry). Journal of Clinical Medicine, 11(21), 6284. https://doi.org/10.3390/jcm11216284